Literature
CytoSure™ Array Handbook (4x44k and 4x180k formats)
Type: Handbook
CytoSure™ Array Handbook (8x15k and 8x60k formats)
Type: Handbook
CytoSure™ HT Array Handbook (8x15k and 8x60k formats)
Type: Handbook
A New Next Generation Sequencing (NGS) Assay for Detecting the Aberrations in Intellectual Disability and Developmental Delay Samples
Presented at ACMG 2020, this poster demonstrates the capability of a novel NGS assay designed to analyse genetic aberrations, including CNVs, SNVs, Indels and LOH, in intellectual disability and developmental delay research samples.
Type: Poster
SureSeq myPanel™ NGS Custom AML Panels
Type: Product profile
SureSeq™ Core MPN Panel
Type: Product profile
Interpret Quick-Start Guide
Download OGT's Interpret NGS analysis software quick-start guide, for use with SureSeq™ and CytoSure™ NGS panels.
Type: Guide
Oxford Gene Technology Expands NGS Offering Into Constitutional Cytogenetics
Oxford Gene Technology recently rolled out its first next-generation sequencing product for constitutional cytogenetics research. The company believes cytogeneticists will adopt its panel to get high-quality single nucleotide variant (SNV) and copy number
Type: Article
CytoSure™ NGS Library Preparation - Instructions for Use
Read and download instructions for use for the CytoSure NGS Library Preparation.
Type: Handbook
Clearance of ctDNA in triple negative and Her2 positive breast cancer patients during neoadjuvant treatment is correlated with pathological complete responses
The primary objective of this study was to assess ctDNA clearance during neoadjuvant treatment as a correlate to effective response to treatment, as benchmarked by clinical complete response (cCR) and pathological complete response (pCR).
Type: Poster
NGS Custom Cancer Panels Overview
Discover the wide range of cancers SureSeq myPanel's pre-optimised NGS custom panel content is available for.
Type: Guide
CytoSure™ Constitutional NGS
Type: Product profile
Interpret NGS Analysis Software – Seamless transition from microarray to NGS in constitutional cytogenetics
At OGT we understand that making the change from microarrays to NGS is a daunting prospect, particularly when it comes to data analysis. This technical note outlines some of the key features we’ve incorporated to help make the change from arrays to NGS as
Type: Application note
SureSeq™ CLL + CNV Panel
Type: Product profile
Assessment of SureSeq™ Interpret software on low-frequency variants using reference standards
Presented at AMP 2019, this poster demonstrates how OGT’s SureSeq Interpret software shows robust and reproducible results in the detection of low-frequency variants using reference standards.
Type: Poster
Find out more
For more information about any OGT product or service, please contact us.